Relation of depressive symptoms to C-reactive protein and pathogen burden (cytomegalovirus, herpes simplex virus, Epstein-Barr virus) in patients with earlier acute coronary syndromes.

PubWeight™: 1.43‹?› | Rank: Top 5%

🔗 View Article (PMID 15670537)

Published in Am J Cardiol on February 01, 2005

Authors

Gregory E Miller1, Kenneth E Freedland, Stephen Duntley, Robert M Carney

Author Affiliations

1: Department of Psychology, University of British Columbia, Vancouver, British Columbia, Canada. gemiller@psych.ubc.ca

Articles citing this

Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol (2005) 8.49

Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol Psychiatry (2007) 2.44

Depression and increased mortality in diabetes: unexpected causes of death. Ann Fam Med (2009) 2.37

Depression subtypes in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr (2014) 1.57

Depression and coronary heart disease. Nat Rev Cardiol (2016) 1.45

Eating ourselves to death (and despair): the contribution of adiposity and inflammation to depression. Prog Neurobiol (2010) 1.38

Inflammation and cancer-related fatigue: mechanisms, contributing factors, and treatment implications. Brain Behav Immun (2012) 1.36

Synergistic relationships among stress, depression, and troubled relationships: insights from psychoneuroimmunology. Depress Anxiety (2013) 1.02

Inflammation and reactivation of latent herpesviruses in older adults. Brain Behav Immun (2011) 1.02

Common genetic contributions to depressive symptoms and inflammatory markers in middle-aged men: the Twins Heart Study. Psychosom Med (2008) 1.01

Relation between C reactive protein and depression remission status in patients presenting with acute coronary syndrome. Heart (2006) 0.95

Biomarkers of systemic inflammation and depression and fatigue in moderate clinically stable COPD. Respir Res (2011) 0.95

The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry (2013) 0.91

Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics. Biodemography Soc Biol (2009) 0.90

Obesity and pain. Br J Pain (2013) 0.88

Childhood adversity and herpesvirus latency in breast cancer survivors. Health Psychol (2012) 0.87

Socioeconomic and psychosocial gradients in cardiovascular pathogen burden and immune response: the multi-ethnic study of atherosclerosis. Brain Behav Immun (2008) 0.87

Serum levels of inflammatory markers in depressed elderly patients with diabetes and mild cognitive impairment. PLoS One (2015) 0.85

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder. Aust N Z J Psychiatry (2011) 0.84

Relation of depression, natural killer cell function, and infections after coronary artery bypass in women. Eur J Cardiovasc Nurs (2007) 0.83

Increased Serum Cu/Zn SOD in Individuals with Clinical Depression Normalizes After Zinc and Anti-oxidant Therapy. Nutr Metab Insights (2010) 0.83

Inflammation in depression: is adiposity a cause? Dialogues Clin Neurosci (2011) 0.83

Depression and coronary heart disease. ISRN Cardiol (2012) 0.82

Helplessness predicts the development of hypertension in older Mexican and European Americans. J Psychosom Res (2009) 0.81

Cardiac Risk Markers and Response to Depression Treatment in Patients With Coronary Heart Disease. Psychosom Med (2016) 0.80

Anxiety and Depression: Linkages with Viral Diseases. Public Health Rev (2012) 0.80

Diabetes, depressive symptoms, and inflammation in older adults: results from the Health, Aging, and Body Composition Study. J Psychosom Res (2013) 0.80

Herpesviruses, inflammatory markers and incident depression in a longitudinal study of Detroit residents. Psychoneuroendocrinology (2014) 0.78

The St. Louis African American health-heart study: methodology for the study of cardiovascular disease and depression in young-old African Americans. BMC Cardiovasc Disord (2013) 0.76

Exhaustion, immuno-inflammation, and pathogen burden after cardiac surgery: an exploratory study. Eur J Cardiovasc Nurs (2013) 0.75

Articles by these authors

Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA (2003) 10.59

Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50

Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81

Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial. JAMA Intern Med (2013) 3.65

Effects of antidepressant medication on morbidity and mortality in depressed patients after myocardial infarction. Arch Gen Psychiatry (2005) 3.41

Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res (2002) 3.27

Depression as a risk factor for mortality after acute myocardial infarction. Am J Cardiol (2003) 2.87

Clinical depression and inflammatory risk markers for coronary heart disease. Am J Cardiol (2002) 2.67

Social support and prognosis in patients at increased psychosocial risk recovering from myocardial infarction. Health Psychol (2007) 2.57

Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation (2014) 2.50

Treatment-resistant depression and mortality after acute coronary syndrome. Am J Psychiatry (2009) 2.49

Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res (2002) 2.41

Depression, the autonomic nervous system, and coronary heart disease. Psychosom Med (2005) 2.36

Changing demographics in REM sleep behavior disorder: possible effect of autoimmunity and antidepressants. Sleep Med (2011) 2.35

Mental stress-induced ischemia and all-cause mortality in patients with coronary artery disease: Results from the Psychophysiological Investigations of Myocardial Ischemia study. Circulation (2002) 2.32

Antidepressant drug compliance: reduced risk of MI and mortality in depressed patients. Am J Med (2011) 2.29

The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom Med (2002) 2.22

Death takes a raincheck. Psychosom Med (2004) 2.10

Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med (2002) 2.02

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute Working Group Report. Psychosom Med (2006) 1.96

Depression, mortality, and medical morbidity in patients with coronary heart disease. Biol Psychiatry (2003) 1.96

Effects of age and amyloid deposition on Aβ dynamics in the human central nervous system. Arch Neurol (2011) 1.87

Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial. JAMA (2009) 1.79

Prevalence of depression in hospitalized patients with congestive heart failure. Psychosom Med (2003) 1.75

Depression in patients with coronary heart disease. Am J Med (2008) 1.73

The selection and design of control conditions for randomized controlled trials of psychological interventions. Psychother Psychosom (2009) 1.70

Low heart rate variability and the effect of depression on post-myocardial infarction mortality. Arch Intern Med (2005) 1.70

Prevalence of undiagnosed obstructive sleep apnea among adult surgical patients in an academic medical center. Sleep Med (2009) 1.69

History of depression and survival after acute myocardial infarction. Psychosom Med (2009) 1.65

Depression and late mortality after myocardial infarction in the Enhancing Recovery in Coronary Heart Disease (ENRICHD) study. Psychosom Med (2004) 1.64

The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovarian syndrome. Sleep Med (2002) 1.62

Medical disorders among patients admitted to a public-sector psychiatric inpatient unit. Psychiatr Serv (2002) 1.61

Pathways linking depression, adiposity, and inflammatory markers in healthy young adults. Brain Behav Immun (2003) 1.60

Chronic interpersonal stress predicts activation of pro- and anti-inflammatory signaling pathways 6 months later. Psychosom Med (2008) 1.59

A simple method to identify sleep apnea using Holter recordings. J Cardiovasc Electrophysiol (2003) 1.56

Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Arch Gen Psychiatry (2006) 1.45

Reverse sleep state misperception. Sleep Med (2004) 1.44

The Great Debate, revisited. Psychosom Med (2006) 1.42

Aspects of social support associated with depression at hospitalization and follow-up assessment among cardiac patients. J Cardiopulm Rehabil (2003) 1.41

Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry (2009) 1.40

Prescription opioid analgesics increase the risk of depression. J Gen Intern Med (2013) 1.37

Telephone-based coping skills training for patients awaiting lung transplantation. J Consult Clin Psychol (2006) 1.33

Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients. Am Heart J (2010) 1.27

Coronary heart disease and depression: a review of recent mechanistic research. Can J Psychiatry (2006) 1.21

Predictors of mortality in younger and older patients with heart failure and preserved or reduced left ventricular ejection fraction. Am Heart J (2003) 1.19

Depression and coronary heart disease in women with diabetes. Psychosom Med (2003) 1.15

Depression and obstructive sleep apnea in patients with coronary heart disease. Psychosom Med (2006) 1.13

Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study. Am Heart J (2006) 1.11

Predictors of treatment response for depression and inadequate social support--the ENRICHD randomized clinical trial. Psychother Psychosom (2007) 1.10

Psychosocial treatment within sex by ethnicity subgroups in the Enhancing Recovery in Coronary Heart Disease clinical trial. Psychosom Med (2004) 1.10

Exercise, depression, and mortality after myocardial infarction in the ENRICHD trial. Med Sci Sports Exerc (2004) 1.10

Heart rate variability and markers of inflammation and coagulation in depressed patients with coronary heart disease. J Psychosom Res (2007) 1.09

Cognitive and somatic symptoms of depression are associated with medical comorbidity in patients after acute myocardial infarction. Am Heart J (2003) 1.09

Psychiatric disorder and quality of life in patients awaiting lung transplantation. Chest (2003) 1.07

Depression and heart rate variability in patients with coronary heart disease. Cleve Clin J Med (2009) 1.07

Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom Med (2007) 1.07

Preexisting cognitive impairment in women before cardiac surgery and its relationship with C-reactive protein concentrations. Anesth Analg (2006) 1.06

The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the Enhancing Recovery in Coronary Heart Disease (ENRICHD) clinical trial. J Cardiopulm Rehabil (2006) 1.05

Depression and five year survival following acute myocardial infarction: a prospective study. J Affect Disord (2008) 1.04

Increased risk of myocardial infarction in depressed patients with type 2 diabetes. Diabetes Care (2011) 1.04

Gas exchange and exercise capacity affect neurocognitive performance in patients with lung disease. Psychosom Med (2005) 1.03

Depression-related hyperglycemia in type 1 diabetes: a mediational approach. Psychosom Med (2005) 1.03

Parental support and cytokine activity in childhood asthma: the role of glucocorticoid sensitivity. J Allergy Clin Immunol (2009) 1.02

Measuring the impact of apnea and obesity on circadian activity patterns using functional linear modeling of actigraphy data. J Circadian Rhythms (2011) 1.01

Depression and smoking in coronary heart disease. Psychosom Med (2005) 1.00

Are somatic symptoms of depression better predictors of cardiac events than cognitive symptoms in coronary heart disease? Psychosom Med (2012) 0.99

Measuring treatment fidelity in a rehabilitation intervention study. Am J Phys Med Rehabil (2012) 0.98

Does treating depression improve survival after acute coronary syndrome? Invited commentary on... Effects of antidepressant treatment following myocardial infarction. Br J Psychiatry (2007) 0.97

Effects of depression on QT interval variability after myocardial infarction. Psychosom Med (2003) 0.96

Depression is a risk factor for mortality in coronary heart disease. Psychosom Med (2004) 0.95

Depression predicts self-reported sleep quality in patients with obstructive sleep apnea. Psychosom Med (2004) 0.94

Association of anxiety disorders and depression with incident heart failure. Psychosom Med (2014) 0.94

Association of anxiety with reduced baroreflex cardiac control in patients after acute myocardial infarction. Am Heart J (2002) 0.92

Obstructive sleep apnea screening and postoperative mortality in a large surgical cohort. Sleep Med (2013) 0.92

Cynical hostility, depressive symptoms, and the expression of inflammatory risk markers for coronary heart disease. J Behav Med (2003) 0.92

Heart rate turbulence, depression, and survival after acute myocardial infarction. Psychosom Med (2006) 0.92

Depression and coronary heart disease: more pieces of the puzzle. Am J Psychiatry (2007) 0.92

Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. Int J Behav Med (2009) 0.91

Assessment and treatment of depression in patients with cardiovascular disease: National Heart, Lung, and Blood Institute working group report. Ann Behav Med (2006) 0.90

Depression and rehospitalization following acute myocardial infarction. Circ Cardiovasc Qual Outcomes (2011) 0.90